3
Participants
Start Date
August 31, 2012
Primary Completion Date
February 28, 2013
Study Completion Date
July 31, 2013
Carboplatin
Carboplatin will be administered intravenously over approximately 30 minutes on day 1 of each cycle. The dosage used will be 5 AUC for the first 5 cycles, and will be increased to 6 AUC for the sixth cycle.
Pazopanib
Pazopanib will be administered orally at 200 to 800 mg/kg2. It will be given either on days 1 through 21 of each 3-week cycle, or if needed, it will be given on days 3 through 19.
University of New Mexico Cancer Center, Albuquerque
Collaborators (1)
GlaxoSmithKline
INDUSTRY
New Mexico Cancer Research Alliance
OTHER